Close menu




September 14th, 2020 | 12:28 CEST

Ballard Power, Nikola, Saturn Oil & Gas - Share price potential with good ideas

  • Investments
Photo credits: pixabay.com

Last Friday, rumors led to an 185% rise in the shares of Canadian exploration company Giga Metals. According to several sources, Tesla plans to purchase nickel and cobalt from this company in British Columbia in the future. The main reason for this is that Giga Metals will be able to operate the mine with hydroelectric power. In addition, environmental regulations in Canada are among the strictest in the world. Against this background, Tesla is able to improve its own CO2 footprint. A sensible and overdue step that hopefully will be imitated.

time to read: 3 minutes | Author: Mario Hose
ISIN: US6541101050 , CA0585861085 , CA80412L1076

Table of contents:


    Better Crude Oil

    The Canadian oil producer Saturn Oil & Gas has been producing oil in the province of Saskatchewan since 2017. In 2019, the company reported its first annual profit since its foundation. Due to the current Corona Pandemic and in connection with the current consolidation phase in the oil sector, CEO John Jeffrey has already announced acquisitions in an earlier news release. In a buyer's market, when the demand side determines the price, it is more advantageous to acquire producing assets rather than to drill yourself time-consuming and cost-intensive wells.

    The management is pursuing the goals of ESG and Saturn Oil & Gas has had dynaCERT CEO Jim Payne on the board since March 2020 as a director. dynaCERT from Canada has recently become a partner of the United Nations and helps cities reduce pollutant emissions with its hydrogen technology. Respect for human rights is a matter of course in Canada and the strict environmental protection requirements for oil production make the country attractive for the procurement of raw materials.

    It is possible that in the future, customers will be able to choose where the fuel will come from at the filling station, similar to coffee beans. Practicable and simple it would be possible if customers could choose the origin of the replacement of the fuel they had previously filled up when paying for it. Petrol station operators would thus have a real competitive advantage over the common practice where the origin is unknown and thus despots and human rights violations could be unknowingly supported. Companies like Saturn Oil & Gas have a special starting position in the future supply of better oil.

    Innovation for the shipping industry

    The Canadian fuel cell manufacturer Ballard Power can help to power electric motors in all vehicles. The special feature of a fuel cell is that it converts the energy carrier hydrogen into electricity. The advantage of fuel cells is that they do not emit pollutants, but to achieve an environmental benefit, hydrogen must be produced from renewable energy sources. In addition to vehicles on land, ships are now also being equipped with fuel cells from Ballard Power.

    Rob Campbell, Ballard's Chief Commercial Officer, recently stated in a press release: "Ballard is focused on heavy- and medium-duty motive applications, particularly where requirements include heavy payload, extended range and rapid refuelling. This is a sweet spot for our fuel cell value proposition, which is backed up by more than 50 million kilometres of operational experience in thousands of vehicles. These same requirements underpin use cases in the maritime industry, resulting in a significant addressable market opportunity that can be effectively addressed by our new FCwave product. Global efforts to decarbonize include commercial maritime activities, where Ballard intends to build on our leading position in zero-emission fuel cell solutions."

    Truth or lie?

    The US company Nikola claims to change the transportation industry worldwide. As a developer and manufacturer of zero-emission battery and hydrogen-electric vehicles, energy storage systems, and the infrastructure for hydrogen filling stations, Nikola strives to revolutionize the economic and environmental impact of commerce. With General Motors, the company was recently able to win a well-known partner.

    In addition to supporters, there are also market participants who do not believe in the success of the company and have doubts about the statements of the boss, Trevor Milton. Hindenburg Research has now published information about the company as a short-seller, which is aimed at reducing the value of the share. This goal is achieved by challenging the credibility of the company and its management. The longer it takes for Nikola to professionally refute Hindenburg's statements, the greater the uncertainty in the market and the price loss for shareholders. If the accusations of the short-seller are credibly refuted, there is a chance of a price rally.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read